EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer
Titel:
EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer
Auteur:
Hamilton, A. Roy, J.-A. Beex, L. Piccart, M. Mauriac, L. Coleman, R. Paridaens, R. Boes, G. Hoctin van Vreckem, A. Palmer, P. Klijn, J.